[Clinical evaluation of "Metet"].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006993:Hypnotics and Sedatives; D007275:Injections, Intravenous; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013440:Sulfides / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use* / Q000031:analogs & derivatives
D000959:Antihypertensive Agents; D006993:Hypnotics and Sedatives; D010919:Placebos; D013440:Sulfides; C001719:metet; D013806:Theophylline
Próby klinicznej oceny preparatu "Metet".